ADAP - Adaptimmune Therapeutics Plc - ADR
IEX Last Trade
1.265
-0.005 -0.395%
Share volume: 984,730
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.27
-0.01
-0.39%
Summary score
10%
Profitability
0%
Dept financing
7%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.05%
Return on assets
-10.96%
Return on sales
-171.7%
Return on invested capital
-71.23%
Total debt ratio
22.75%
Debt ratio change over timeo
-0.66%
Current Ratio
6.44%
Quick Ratio
0%
Cash Position Ratio
2.79%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.25%
Return on assets
-14.46%
Return on sales
0%
Return on invested capital
-142.35%
Total debt ratio
29.05%
Debt ratio change over timeo
-1.24%
Current Ratio
6.74%
Quick Ratio
0%
Cash Position Ratio
2.15%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.35%
Return on assets
-6.67%
Return on sales
0%
Return on invested capital
-192.56%
Total debt ratio
20.42%
Debt ratio change over time
-1.2%
Current Ratio
11.88%
Quick Ratio
0%
Cash Position Ratio
3.17%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.58%
Return on assets
-116.2%
Return on sales
-95.57%
Return on invested capital
313.5%
Total debt ratio
-65.53%
Debt ratio change over time
-0.66%
Current Ratio
3%
Quick Ratio
0%
Cash Position Ratio
0.47%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADAP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.05% | -3.05% | 11.55% | 6.27% |
| Return on assets | -10.96% | 3.6% | 3.57% | 5.27% |
| Return on sales | -171.7% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -71.23% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 22.75% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.66% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 6.74% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.15% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 23% | 44% | 49% |
| Short-term ratios | ADAP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.25% | -25.62% | 17.94% | 7.14% |
| Return on assets | -14.46% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -142.35% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 29.05% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.24% | -23.44% | 9.66% | 0.6% |
| Dept financing | 7% | 25% | 45% | 8% |
| Current Ratio | 6.74% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.15% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 42% | 31% | 55% |